Back to search

Article

AAV Kills Dividing Cells by Depleting PARP1 and Other DNA Damage Response Proteins

2025-10-15

Abstract excerpt

Recombinant adeno-associated virus (rAAV) is a replication-defective viral vector used in hundreds of human gene therapy trials, resulting in five FDA-approved therapies. Despite this success, rAAV-based gene therapies suffer from dose-limiting toxicities, resulting in several severe adverse reactions, including death. Previously, we discovered that rAAV rapidly kills mouse NPCs in vitro and in vivo. This vector c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
722e9f49-7a2c-5544-b07e-933cc2069e4c
DOI
10.1101/2025.10.14.682484
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
AAV Kills Dividing Cells by Depleting PARP1 and Other DNA Damage Response ProteinsDOI 10.1101/2025.10.14.682484
Select a neighboring publication to make it the new centre.